Spatial analysis of colorectal cancer outcomes and socioeconomic factors in Virginia.
Colorectal neoplasms
Incidence
Risk factors
Spatial regression
Virginia
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
21 10 2021
21 10 2021
Historique:
received:
29
04
2021
accepted:
28
09
2021
entrez:
22
10
2021
pubmed:
23
10
2021
medline:
3
11
2021
Statut:
epublish
Résumé
Colorectal cancer (CRC) disparities vary by country and population group, but often have spatial features. This study of the United States state of Virginia assessed CRC outcomes, and identified demographic, socioeconomic and healthcare access contributors to CRC disparities. County- and city-level cross-sectional data for 2011-2015 CRC incidence, mortality, and mortality-incidence ratio (MIR) were analyzed for geographically determined clusters (hotspots and cold spots) and their correlates. Spatial regression examined predictors including proportion of African American (AA) residents, rural-urban status, socioeconomic (SES) index, CRC screening rate, and densities of primary care providers (PCP) and gastroenterologists. Stationarity, which assesses spatial equality, was examined with geographically weighted regression. For incidence, one CRC hotspot and two cold spots were identified, including one large hotspot for MIR in southwest Virginia. In the spatial distribution of mortality, no clusters were found. Rurality and AA population were most associated with incidence. SES index, rurality, and PCP density were associated with spatial distribution of mortality. SES index and rurality were associated with MIR. Local coefficients indicated stronger associations of predictor variables in the southwestern region. Rurality, low SES, and racial distribution were important predictors of CRC incidence, mortality, and MIR. Regions with concentrations of one or more factors of disparities face additional hurdles to improving CRC outcomes. A large cluster of high MIR in southwest Virginia region requires further investigation to improve early cancer detection and support survivorship. Spatial analysis can identify high-disparity populations and be used to inform targeted cancer control programming.
Sections du résumé
BACKGROUND
Colorectal cancer (CRC) disparities vary by country and population group, but often have spatial features. This study of the United States state of Virginia assessed CRC outcomes, and identified demographic, socioeconomic and healthcare access contributors to CRC disparities.
METHODS
County- and city-level cross-sectional data for 2011-2015 CRC incidence, mortality, and mortality-incidence ratio (MIR) were analyzed for geographically determined clusters (hotspots and cold spots) and their correlates. Spatial regression examined predictors including proportion of African American (AA) residents, rural-urban status, socioeconomic (SES) index, CRC screening rate, and densities of primary care providers (PCP) and gastroenterologists. Stationarity, which assesses spatial equality, was examined with geographically weighted regression.
RESULTS
For incidence, one CRC hotspot and two cold spots were identified, including one large hotspot for MIR in southwest Virginia. In the spatial distribution of mortality, no clusters were found. Rurality and AA population were most associated with incidence. SES index, rurality, and PCP density were associated with spatial distribution of mortality. SES index and rurality were associated with MIR. Local coefficients indicated stronger associations of predictor variables in the southwestern region.
CONCLUSIONS
Rurality, low SES, and racial distribution were important predictors of CRC incidence, mortality, and MIR. Regions with concentrations of one or more factors of disparities face additional hurdles to improving CRC outcomes. A large cluster of high MIR in southwest Virginia region requires further investigation to improve early cancer detection and support survivorship. Spatial analysis can identify high-disparity populations and be used to inform targeted cancer control programming.
Identifiants
pubmed: 34674672
doi: 10.1186/s12889-021-11875-6
pii: 10.1186/s12889-021-11875-6
pmc: PMC8529747
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1908Subventions
Organisme : NCI NIH HHS
ID : P20 CA233216
Pays : United States
Informations de copyright
© 2021. The Author(s).
Références
J Community Health. 2017 Oct;42(5):1044-1061
pubmed: 28439739
Gastroenterology. 2018 Nov;155(5):1383-1391.e5
pubmed: 30031768
JAMA Surg. 2014 Jun;149(6):537-43
pubmed: 24740165
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
PLoS One. 2015 Jun 25;10(6):e0131578
pubmed: 26110832
Appl Geogr. 2015 Aug 1;62:191-200
pubmed: 26257450
Int J Health Geogr. 2011 Jul 25;10:44
pubmed: 21787394
BMC Med Res Methodol. 2013 Mar 24;13:49
pubmed: 23522349
BMC Cancer. 2013 Oct 24;13:493
pubmed: 24152961
J Glob Oncol. 2019 May;5:1-9
pubmed: 31070980
Am Soc Clin Oncol Educ Book. 2021 Mar;41:108-117
pubmed: 34010044
Cad Saude Publica. 2002 May-Jun;18(3):633-7
pubmed: 12048589
Am J Public Health. 2014 Mar;104(3):e63-71
pubmed: 24432920
Health Serv Res. 2014 Apr;49(2):546-67
pubmed: 24117371
Am J Prev Med. 2016 Oct;51(4):e107-15
pubmed: 27050413
J Oncol Pract. 2015 Jan;11(1):e9-e18
pubmed: 25228530
Am J Public Health. 2013 Jan;103(1):99-104
pubmed: 23153135
Am J Prev Med. 2006 Feb;30(2 Suppl):S67-76
pubmed: 16458792
J Urban Health. 2017 Apr;94(2):199-210
pubmed: 28290007
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
BMC Res Notes. 2020 Dec 9;13(1):560
pubmed: 33298152
Prev Chronic Dis. 2014 Mar 20;11:E41
pubmed: 24650619
Cancer Med. 2012 Dec;1(3):350-6
pubmed: 23342284
Stat Med. 2005 Sep 15;24(17):2695-717
pubmed: 16118814
Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1151-6
pubmed: 26156973
Cancer Epidemiol Biomarkers Prev. 2018 Nov;27(11):1265-1274
pubmed: 28751476
Int J Health Geogr. 2011 Sep 26;10:51
pubmed: 21943079
Nat Rev Gastroenterol Hepatol. 2019 Dec;16(12):713-732
pubmed: 31455888
J Rural Health. 2017 Sep;33(4):345-349
pubmed: 28905432
BMC Cancer. 2018 Jan 06;18(1):40
pubmed: 29304835
Geospat Health. 2019 Nov 06;14(2):
pubmed: 31724371
Ann Thorac Surg. 2019 Aug;108(2):412-416
pubmed: 30951691
Cancer. 2015 May 15;121(10):1563-9
pubmed: 25572676
Cancer. 2016 Jun 1;122(11):1735-48
pubmed: 26969874
MMWR Surveill Summ. 2011 Aug 19;60(9):1-250
pubmed: 21849967
Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):250-8
pubmed: 26819264
BMC Cancer. 2020 Nov 30;20(1):1170
pubmed: 33256668
Prev Med. 2019 Dec;129S:105835
pubmed: 31520673
Med J Islam Repub Iran. 2019 Mar 27;33:23
pubmed: 31380313
J Community Health. 2015 Aug;40(4):633-41
pubmed: 25634545
Ann Agric Environ Med. 2019 Mar 22;26(1):125-132
pubmed: 30922042
J Rural Health. 2017 Sep;33(4):375-381
pubmed: 27602545